6 Recruiting Kaposi Sarcoma Phase 2 Clinical Trials
Active phase 2 studies for kaposi sarcoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Kaposi Sarcoma studiesPhase 2 Studies for Kaposi Sarcoma
🟡 Not Yet Recruiting Phase2
A Study of Propranolol to Treat Kaposi Sarcoma
📍 Fundación Huésped — Buenos Aires,
View Study & Checklist ➔ 🟢 Recruiting Phase2
Propranolol for the Treatment of Kaposi Sarcoma in Adults
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Trial of Ixazomib for Kaposi Sarcoma
📍 UC San Diego — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔